These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25983009)

  • 21. Remote monitoring of subcutaneous implantable cardioverter defibrillators.
    De Filippo P; Luzi M; D'Onofrio A; Bongiorni MG; Giammaria M; Bisignani G; Menardi E; Ferrari P; Bianchi V; Viani S; Leidi C; Lovecchio M; Valsecchi S; Capucci A
    J Interv Card Electrophysiol; 2018 Dec; 53(3):373-381. PubMed ID: 30276592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of remote monitoring of cardiac implantable electronic devices after stroke or transient ischemic attack.
    De Simone V; Zanotto G; Guarise P; Venturato A; Cassinadri E; Bassi M; Bozzolin M; Tondelli S; Giacopelli D; Morando G
    J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):551-556. PubMed ID: 31157660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment.
    Piccini JP; Mittal S; Snell J; Prillinger JB; Dalal N; Varma N
    Heart Rhythm; 2016 Dec; 13(12):2279-2286. PubMed ID: 27544748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards eradication of inappropriate therapies for ICD lead failure by combining comprehensive remote monitoring and lead noise alerts.
    Ploux S; Swerdlow CD; Strik M; Welte N; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1125-1134. PubMed ID: 29858871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator.
    Denollet J; Tekle FB; Pedersen SS; van der Voort PH; Alings M; van den Broek KC
    Int J Cardiol; 2013 Sep; 167(6):2705-9. PubMed ID: 22809538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of implantable cardioverter defibrillator home monitoring in forecasting the need for regular office visits, and patient perspective. Japanese HOME-ICD study.
    Watanabe E; Kasai A; Fujii E; Yamashiro K; Brugada P
    Circ J; 2013; 77(11):2704-11. PubMed ID: 23903000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remote monitoring of implantable cardiac devices in heart failure patients: a systematic review and meta-analysis of randomized controlled trials.
    Alotaibi S; Hernandez-Montfort J; Ali OE; El-Chilali K; Perez BA
    Heart Fail Rev; 2020 May; 25(3):469-479. PubMed ID: 32002732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
    Santangeli P; Muser D; Maeda S; Filtz A; Zado ES; Frankel DS; Dixit S; Epstein AE; Callans DJ; Marchlinski FE
    Heart Rhythm; 2016 Jul; 13(7):1552-9. PubMed ID: 26961297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A report on the impact of remote monitoring in patients with S-ICD: Insights from a prospective registry.
    Ninni S; Delahaye C; Klein C; Marquie C; Klug D; Lacroix D; Brigadeau F; Potelle C; Kouakam C; Finat L; Guedon-Moreau L
    Pacing Clin Electrophysiol; 2019 Mar; 42(3):349-355. PubMed ID: 30609077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remote versus in-office monitoring for implantable cardioverter defibrillators: Results from a randomized pragmatic controlled study in Portugal.
    Oliveira M; Fernandes M; Reis H; Primo J; Sanfins V; Silva V; Cunha PS; Silva M; Nicola PJ;
    Rev Port Cardiol; 2022 Dec; 41(12):987-997. PubMed ID: 36229282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.
    Gasparini M; Proclemer A; Klersy C; Kloppe A; Lunati M; Ferrer JB; Hersi A; Gulaj M; Wijfels MC; Santi E; Manotta L; Arenal A
    JAMA; 2013 May; 309(18):1903-11. PubMed ID: 23652522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Device therapy: Remote monitoring-the benefits of keeping in touch.
    Phillips R
    Nat Rev Cardiol; 2015 Jul; 12(7):380. PubMed ID: 26031697
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-effectiveness of remote monitoring of implantable cardioverter-defibrillators in France: a meta-analysis and an integrated economic model derived from randomized controlled trials.
    Sequeira S; Jarvis CI; Benchouche A; Seymour J; Tadmouri A
    Europace; 2020 Jul; 22(7):1071-1082. PubMed ID: 32424395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remote monitoring of cardiovascular devices: a time and activity analysis.
    Cronin EM; Ching EA; Varma N; Martin DO; Wilkoff BL; Lindsay BD
    Heart Rhythm; 2012 Dec; 9(12):1947-51. PubMed ID: 22864266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
    Braunschweig F; Anker SD; Proff J; Varma N
    Europace; 2019 Jun; 21(6):846-855. PubMed ID: 30903152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area.
    Callum K; Graune C; Bowman E; Molden E; Leslie SJ
    World J Cardiol; 2021 Mar; 13(3):46-54. PubMed ID: 33791078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up.
    Buchta P; Tajstra M; Kurek A; Skrzypek M; Świetlińska M; Gadula-Gacek E; Wasiak M; Pyka Ł; Gąsior M
    Kardiol Pol; 2017; 75(6):573-580. PubMed ID: 28150288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced cardiac device management utilizing the random EGM: A neglected feature of remote monitoring.
    Ploux S; Eschalier R; Varma N; Ritter P; Klotz N; Haïssaguerre M; Bordachar P
    Heart Rhythm; 2016 Feb; 13(2):602-8. PubMed ID: 26432581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.